Behet disease: Visual prognosis and factors influencing the development of visual loss

American Journal of Ophthalmology

Volumn 152, Issue 6, 2011, Pages 1059-1066

  Taylor, Simon R J ^a,b   Singh, Jasmin ^a,b   Menezo, Victor ^c   Wakefield, Denis ^d   McCluskey, Peter ^c   Lightman, Sue ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; ETANERCEPT; INFLIXIMAB; METHYLPREDNISOLONE ACETATE; PREDNISOLONE; TRIAMCINOLONE ACETATE; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BEHCET DISEASE; BRANCH RETINAL VEIN OCCLUSION; CASE STUDY; CENTRAL RETINA ARTERY OCCLUSION; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; EYE EXAMINATION; FEMALE; FOLLOW UP; HUMAN; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; MALE; OPTIC NERVE DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RETINA DETACHMENT; RETINA MACULOPATHY; RETROSPECTIVE STUDY; RISK FACTOR; SCLERITIS; SEX DIFFERENCE; UVEITIS; VISUAL ACUITY; VISUAL IMPAIRMENT; ADOLESCENT; BLINDNESS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VISUAL DISORDER;

ADOLESCENT; ADULT; BEHCET SYNDROME; BLINDNESS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PREDNISOLONE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; VISION, LOW; VISUAL ACUITY; YOUNG ADULT;

EID: 81855202036     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2011.05.032     Document Type: Article

References (34)

1. C.M. Deuter, I. Kotter, G.R. Wallace, P.I. Murray, N. Stubiger, and M. Zierhut Behet's disease: ocular effects and treatment Prog Retin Eye Res 27 1 2008 111 136
2. C. Evereklioglu Current concepts in the etiology and treatment of Behet disease Surv Ophthalmol 50 4 2005 297 350 (Pubitemid 40828225)
3. I. Tugal-Tutkun, S. Onal, R. Altan-Yaycioglu, H. Huseyin Altunbas, and M. Urgancioglu Uveitis in Behet disease: an analysis of 880 patients Am J Ophthalmol 138 3 2004 373 380 (Pubitemid 39208563)
4. J.V. Ghate, and J.L. Jorizzo Behet's disease and complex aphthosis J Am Acad Dermatol 40 1 1999 1 18 quiz 1920
5. V.G. Kaklamani, and P.G. Kaklamanis Treatment of Behet's diseasean update Semin Arthritis Rheum 30 5 2001 299 312
6. R.O. Kacmaz, J.H. Kempen, and C. Newcomb Ocular inflammation in Behet disease: incidence of ocular complications and of loss of visual acuity Am J Ophthalmol 146 6 2008 828 836
7. F. Saenz-Frances, M. Elias-de-Tejada, and J.M. Martinez-de-la-Casa Ocular inflammatory signs observed in a cohort of Spanish patients with Behet disease and ocular inflammation Eur J Ophthalmol 18 4 2008 563 566
8. S. Ozen Vasculopathy, Behet's syndrome, and familial Mediterranean fever Curr Opin Rheumatol 11 5 1999 393 398
9. U. Tursen, A. Gurler, and A. Boyvat Evaluation of clinical findings according to sex in 2313 Turkish patients with Behet's disease Int J Dermatol 42 5 2003 346 351 (Pubitemid 36681714)
10. T. Sakane, M. Takeno, N. Suzuki, and G. Inaba Behet's disease N Engl J Med 341 17 1999 1284 1291
11. D. Ben-Ezra, and E. Cohen Treatment and visual prognosis in Behet's disease Br J Ophthalmol 70 8 1986 589 592 (Pubitemid 16038279)
12. H. Yazici, and C.G. Barnes Practical treatment recommendations for pharmacotherapy of Behet's syndrome Drugs 42 5 1991 796 804 (Pubitemid 21920785)
13. J.B. Michelson, and F.V. Chisari Behet's disease Surv Ophthalmol 26 4 1982 190 203
14. S.R. Boyd, S. Young, and S. Lightman Immunopathology of the noninfectious posterior and intermediate uveitides Surv Ophthalmol 46 3 2001 209 233 (Pubitemid 34003577)
15. K. Ando, Y. Fujino, K. Hijikata, Y. Izawa, and K. Masuda Epidemiological features and visual prognosis of Behet's disease Jpn J Ophthalmol 43 4 1999 312 317 (Pubitemid 29329392)
16. R.B. Nussenblatt Uveitis in Behet's disease Int Rev Immunol 14 1 1997 67 79
17. M. Sakamoto, K. Akazawa, Y. Nishioka, H. Sanui, H. Inomata, and Y. Nose Prognostic factors of vision in patients with Behet disease Ophthalmology 102 2 1995 317 321
18. I. Tugal-Tutkun, A. Mudun, and M. Urgancioglu Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behet's disease: an open-label trial Arthritis Rheum 52 8 2005 2478 2484 (Pubitemid 41117435)
19. S. Ohno, S. Nakamura, and S. Hori Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behet's disease with refractory uveoretinitis J Rheumatol 31 7 2004 1362 1368 (Pubitemid 38879203)
20. Criteria for diagnosis of Behet's disease International Study Group for Behet's Disease Lancet 335 8697 1990 1078 1080
21. D.A. Jabs, J.T. Rosenbaum, and C.S. Foster Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel Am J Ophthalmol 130 4 2000 492 513
22. D.A. Jabs, R.B. Nussenblatt, J.T. Rosenbaum Standardization of Uveitis Nomenclature Working G Standardization of uveitis nomenclature for reporting clinical data Results of the First International Workshop Am J Ophthalmol 140 3 2005 509 516 (Pubitemid 41224845)
23. H. Yazici, H. Pazarli, and C.G. Barnes A controlled trial of azathioprine in Behet's syndrome N Engl J Med 322 5 1990 281 285 (Pubitemid 20046329)
24. M. Takeuchi, H. Hokama, and R. Tsukahara Risk and prognostic factors of poor visual outcome in Behet's disease with ocular involvement Graefes Arch Clin Exp Ophthalmol 243 11 2005 1147 1152 (Pubitemid 43124166)
25. A. Ambresin, T. Tran, F. Spertini, and C. Herbort Behet's disease in Western Switzerland: epidemiology and analysis of ocular involvement Ocul Immunol Inflamm 10 1 2002 53 63 (Pubitemid 36042847)
26. L.S. Atmaca Fundus changes associated with Behet's disease Graefes Arch Clin Exp Ophthalmol 227 4 1989 340 344 (Pubitemid 19180482)
27. C. Barra, R. Belfort Junior, M.T. Abreu, M.K. Kim, M.C. Martins, and A.M. Petrilli Behet's disease in Brazila review of 49 cases with emphasis on ophthalmic manifestations Jpn J Ophthalmol 35 3 1991 339 346
28. H. Demiroglu, I. Barista, and S. Dundar Risk factor assessment and prognosis of eye involvement in Behet's disease in Turkey Ophthalmology 104 4 1997 701 705 (Pubitemid 27171995)
29. S. Mishima, K. Masuda, Y. Izawa, M. Mochizuki, and K. Namba The eighth Frederick H Verhoeff Lecture. Presented by Saiichi Mishima, MD. Behet's disease in Japan: ophthalmologic aspects Trans Am Ophthalmol Soc 77 1979 225 279 (Pubitemid 10072809)
30. P.C. Ozdal, S. Ortac, I. Taskintuna, and E. Firat Posterior segment involvement in ocular Behet's disease Eur J Ophthalmol 12 5 2002 424 431 (Pubitemid 35428797)
31. C.M. Deuter, I. Kotter, I. Gunaydin, M. Zierhut, and N. Stubiger [Ocular involvement in Behet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a] Ophthalmologe 101 2 2004 129 134 (Pubitemid 38295555)
32. L. Krause, A. Altenburg, U. Pleyer, A.K. Kohler, C.C. Zouboulis, and M.H. Foerster Longterm visual prognosis of patients with ocular Adamantiades-Behet's disease treated with interferon-alpha-2a J Rheumatol 35 5 2008 896 903 (Pubitemid 351747134)
33. D.S. Yang, S.R. Taylor, and S.L. Lightman Interferon-alpha in the management of patients with Behet's disease Br J Hosp Med (Lond) 69 10 2008 575 579
34. K.F. Tabbara, and A.I. Al-Hemidan Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behet disease Am J Ophthalmol 146 6 2008 845 850